openPR Logo
Press release

A new type of app for Apple Watch Electrocardiogram: 'VAGUS ECG helping your health'

03-08-2021 05:09 PM CET | Health & Medicine

Press release from: Vagus Health Ltd.

VAGUS ECG - helping your health with Apple Watch ECG

VAGUS ECG - helping your health with Apple Watch ECG

Vagus ECG: A new use case for Apple Watch Electrocardiogram (ECG)
Vagus Health launches a ground breaking stress and health monitoring app

Based on seven years of research in Cambridge (UK) and Helsinki (Finland) Vagus Health Ltd, a bioelectronics company, has developed a novel way to measure breathing and state of the vagus nerve (the body’s most important nerve) with a smartwatch ECG

Vagus Health has launched VAGUS® ECG, a ground breaking ECG (Electrocardiogram) based health app for Apple Watch. The app brings to the market completely new technology to monitor stress and wellbeing. The new Vagus ECG app provides Apple Watch users with a better understanding of their health with a 30 second ECG test. The app uses advanced cloud-based data analytics and complex AI-driven analytics to summarise results and advice in an easy-to-understand way.

“When I experienced a burnout in 2010, I started to develop brain stimulation methods. We developed a stimulation device for reducing anxiety attacks and achieving a state of relaxation but realized that we also needed to develop better diagnostics to personalize the stimulation. This resulted in the Vagus ECG app.”, said Gustaf Kranck, the founder and CEO of Vagus Health. “We make our own Vagus ECG Smartwatch, but my team and I were very pleased when Apple end of last year decided to open the interface and data for its ECG sensor. It enabled us to make the app so that our analysis now also can help millions of Apple Watch owners.”

The core of the research of Vagus Health has been in understanding how the vagus nerve synchronizes the heart and breathing. By doing the Vagus ECG test with controlled breathing, the unique analysis calculates exactly how the person is breathing and how well the heart beats are correlated with each breath. This oxygenation process is determined by the vagus nerve. “First, we tried to calculate it with heart rate variability (HRV), but it was not precise enough. We then discovered a new way to calculate breathing from the ECG electrical signal itself. It changed everything. This data opened Pandora's box in terms of better knowledge about the vagus nerve and the user’s health”, explains Gustaf Kranck.

Dave Asprey, ‘Father of biohacking’, Founder of Bulletproof and author of New York Times bestseller The Bulletproof Diet comments on the technology developed by Vagus Health: “This is one of the most cutting-edge ways I’ve ever seen to know how your nervous system is really doing – far more promise than even Heart Rate Variability, which was the gold standard.”

The Vagus ECG app is formally launched on Clubhouse tomorrow 9th of March during Gustaf Kranck’s weekly ‘VAGUS’ talks.

ABOUT VAGUS HEALTH LTD
Vagus Health Ltd is a Cambridge (UK) based bioelectronics company founded in 2017. Its focus is to develop vagus nerve diagnostics- and stimulation technology to measure and treat stress-, anxiety- and immune system related health problems. The team is from Finland, Sweden and the UK. The founders Gustaf Kranck and Mattias Nordström have worked together since 2013. The name of the company comes from the vagus nerve, the longest and most important nerve bundle in the body. This nerve is the company’s focus for greater understanding of the person's health and how to provide individualized treatments.

INTRODUCTORY OFFER: Free Trial during first week for all new users.

The Vagus ECG app is subscription based, charged quarterly:
US: 6.66 $/month (19.99$/3m), UK: 6.50£/month (19.49£/3m)
EU: 7.33 €/month (21.99€/3m), Japan: 700 ¥/month (2100¥/3m)

Demo video about the Vagus ECG app: https://youtu.be/LKMFQOWTY7c

CONTACT

For more information, please contact Gustaf Kranck, founder and CEO: gustaf@vagus.co
Tel +358 400 501 991

Please visit www.vagus.co, https://vagus.co/science/ or https://vagus.co/applewatch/
The Vagus ECG app on app store: Vagus ECG App
Media documents and pictures: https://bit.ly/3s97uSU

‘VAGUS®’ is registered trademark for Vagus Health Ltd.

*The Vagus ECG app for Apple Watch and the Vagus ECG Test analytics are not medical diagnostics tools. The analytics, advice and risk assessments presented by the Vagus ECG app should not be used as medical diagnostics. They should not be used to decide alternations or additions to medical treatments without consulting a medical doctor or certified professional.

St Johns Innovation Centre, Cowley Rd, Cambridge CB4 0WS, United Kingdom
Gustaf Kranck, CEO, gustaf@vagus.co

Vagus Health Ltd is a Cambridge (UK) based bioelectronics company founded in 2017. Its focus is to develop vagus nerve diagnostics- and stimulation technology to measure and treat stress-, anxiety- and immune system related health problems. The team is from Finland, Sweden and the UK. The founders Gustaf Kranck and Mattias Nordström have worked together since 2013. The name of the company comes from the vagus nerve, the longest and most important nerve bundle in the body. This nerve is the company’s focus for greater understanding of the person's health and how to provide individualized treatments.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A new type of app for Apple Watch Electrocardiogram: 'VAGUS ECG helping your health' here

News-ID: 2253551 • Views:

More Releases for ECG

ECG Cable and ECG Lead Wires Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘ECG Cable and ECG Lead Wires Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the ECG Cable and ECG Lead Wires Market. Increased demand for the technologies is also one of the factors, which are likely to boost
ECG Cable and ECG Lead Wires Market Opportunity Analysis, 2018-2026
Electrocardiograph machines are used to measure the electrical activity of a patient’s heart. The electrical activity of the heart is recorded with the help of 12-lead ECGs and 10 electrodes placed on patient’s limbs and surface of the chest. Furthermore, ECG applies to monitor the patient’s emergency situation to obtain quick results of heart’s size, position of heart chambers, the rate of the heart, rhythm, and any damage to heart
Diagnostic Electrocardiograph (ECG) Market Report 2018: Segmentation by Product …
Global Diagnostic Electrocardiograph (ECG) market research report provides company profile for Fukuda Denshi, Welch Allyn, Mortara Instrument, NIHON KOHDEN, GE Healthcare, Philips, BioTelemetry, Suzuken and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The
ECG Cables and ECG Lead Wires Market succouring demand 2025
Global ECG Cables and ECG Lead Wires Market: Snapshot ECG cables and lead wires are a key equipment needed for electrocardiography, a monitoring technique used in several cardiac diseases. The global ECG cables and lead wires market has thus been driven primarily by the rising prevalence of cardiovascular conditions among the modern urban demographic and the growth of the geriatric demographic, which has led to rising demand for cardiac monitoring equipment.
Global ECG cables and ECG leadwires Sales Market industry Report 2017
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global ECG cables and ECG leadwires Sales Market” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for Medical Equipments would rise at a positive CAGR during the period 2017-2022.
ECG Equipment & Management System Market Analysis By Type (Holter Monitors, Rest …
Introduction Electrocardiogram (ECG) devices record and test the cardio activity electrically. The electrical impulse that is generated by cardiac tissues is recorded by ECG by polarization and depolarization mechanism. ECG devices are of excessive help to physicians and cardiologist for proper and early detection of cardiac disorders and diagnosis like inflammation of heart, abnormal heart rhythm, congenital heart defect, poor supply of blood to the arteries and many more. ECG stress